<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Neuropsychopharmacology</journal-id>
<journal-id journal-id-type="iso-abbrev">Neuropsychopharmacology</journal-id>
<journal-title-group>
<journal-title>Neuropsychopharmacology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0893-133X</issn>
<issn pub-type="epub">1740-634X</issn>
<publisher>
<publisher-name>Nature Publishing Group</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26499511</article-id>
<article-id pub-id-type="pmc">4832024</article-id>
<article-id pub-id-type="pii">npp2015323</article-id>
<article-id pub-id-type="doi">10.1038/npp.2015.323</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A Role for Diminished GABA Transporter Activity in the Cortical Discharge Phenotype of MeCP2-Deficient Mice</article-title>
<alt-title alt-title-type="running">Cortical excitability in MeCP2-deficient mice</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Liang</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wither</surname>
<given-names>Robert G</given-names>
</name>
<xref ref-type="aff" rid="aff4">4</xref>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lang</surname>
<given-names>Min</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff4">4</xref>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Chiping</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sidorova-Darmos</surname>
<given-names>Elena</given-names>
</name>
<xref ref-type="aff" rid="aff4">4</xref>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Netchev</surname>
<given-names>Hristo</given-names>
</name>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Matolcsy</surname>
<given-names>Catherine B</given-names>
</name>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Snead</surname>
<given-names>Orlando Carter</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eubanks</surname>
<given-names>James H</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff4">4</xref>
<xref ref-type="aff" rid="aff5">5</xref>
<xref ref-type="aff" rid="aff6">6</xref>
<xref ref-type="corresp" rid="caf1">*</xref>
</contrib>
<aff id="aff1"><label>1</label><institution>Division of Fundamental Neurobiology, Toronto Western Research Institute, University Health Network</institution>, Toronto, ON, <country>Canada</country></aff>
<aff id="aff2"><label>2</label><institution>University of Toronto Epilepsy Research Program, University of Toronto</institution>, Toronto, ON, <country>Canada</country></aff>
<aff id="aff3"><label>3</label><institution>Department of Medicine (Neurology), University of Toronto</institution>, Toronto, ON, <country>Canada</country></aff>
<aff id="aff4"><label>4</label><institution>Division of Genetics and Development, Toronto Western Research Institute, University Health Network</institution>, Toronto, ON, <country>Canada</country></aff>
<aff id="aff5"><label>5</label><institution>Department of Physiology, University of Toronto</institution>, Toronto, ON, <country>Canada</country></aff>
<aff id="aff6"><label>6</label><institution>Department of Surgery (Neurosurgery), University of Toronto</institution>, Toronto, ON, <country>Canada</country></aff>
</contrib-group>
<author-notes>
<corresp id="caf1"><label>*</label><institution>Toronto Western Hospital</institution>, 8KD-417, 60 Leonard Avenue, Toronto, ON M5T 2S8, <country>Canada</country>, Tel: +1 416 603 5800, ext. 2933, Fax: +1 416 603 5745, E-mail: <email>jeubanks@uhnres.utoronto.ca</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>05</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epreprint">
<day>26</day>
<month>10</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="epub">
<day>18</day>
<month>11</month>
<year>2015</year>
</pub-date>
<volume>41</volume>
<issue>6</issue>
<fpage>1467</fpage>
<lpage>1476</lpage>
<history>
<date date-type="received">
<day>21</day>
<month>05</month>
<year>2015</year>
</date>
<date date-type="rev-recd">
<day>13</day>
<month>09</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>01</day>
<month>10</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2016 American College of Neuropsychopharmacology</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>American College of Neuropsychopharmacology</copyright-holder>
</permissions>
<abstract>
<p>Cortical network hyper-excitability is a common phenotype in mouse models lacking the transcriptional regulator methyl-CPG-binding protein 2 (MeCP2). Here, we implicate enhanced GABA<sub>B</sub> receptor activity stemming from diminished cortical expression of the GABA transporter GAT-1 in the genesis of this network hyper-excitability. We found that administering the activity-dependent GABA<sub>B</sub> receptor allosteric modulator GS-39783 to female <italic>Mecp2</italic><sup>+/−</sup> mice at doses producing no effect in wild-type mice strongly potentiated their basal rates of spontaneous cortical discharge activity. Consistently, administering the GABA<sub>B</sub> receptor antagonist CGP-35348 significantly decreased basal discharge activity in these mice. Expression analysis revealed that while GABA<sub>B</sub> or extra-synaptic GABA<sub>A</sub> receptor prevalence is preserved in the MeCP2-deficient cortex, the expression of GAT-1 is significantly reduced from wild-type levels. This decrease in GAT-1 expression is consequential, as low doses of the GAT-1 inhibitor NO-711 that had no effects in wild-type mice strongly exacerbated cortical discharge activity in female <italic>Mecp2</italic><sup>+/−</sup> mice. Taken together, these data indicate that the absence of MeCP2 leads to decreased cortical levels of the GAT-1 GABA transporter, which facilitates cortical network hyper-excitability in MeCP2-deficient mice by increasing the activity of cortical GABA<sub>B</sub> receptors.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>